Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Artificial Intelligence in Medicine|January 13, 2015
Predictive modelling of survival and length of stay in critically ill patients using sequential organ failure scoresRein Houthooft, Joeri Ruyssinck, Joachim van der Herten, et al.
Critical Care (London, England)|May 7, 2013
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Sofie Carrette, Jason A Roberts, et al.
Artificial Intelligence in Medicine|January 19, 2021
Overly optimistic prediction results on imbalanced data: a case study of flaws and benefits when applying over-samplingGilles Vandewiele, Isabelle Dehaene, György Kovács, et al.
Critical Care Medicine|March 28, 2009
Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: a comparison between middle-aged, old, and very old patientsStijn Blot, Mustafa Cankurtaran, Mirko Petrovic, et al.
Chest|May 17, 2014
Inappropriate care in European ICUs: confronting views from nurses and junior and senior physiciansRuth D Piers, Elie Azoulay, Bara Ricou, et al.
Annals of Surgery|March 5, 2003
Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation?Roberto Troisi, Guy Cammu, Giuseppe Militerno, et al.
EMBO Molecular Medicine|January 10, 2020
Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsisLise Van Wyngene, Tineke Vanderhaeghen, Steven Timmermans, et al.
JAMA|December 29, 2011
Perceptions of appropriateness of care among European and Israeli intensive care unit nurses and physiciansRuth D Piers, Elie Azoulay, Bara Ricou, et al.
Intensive Care Medicine|November 7, 2019
Ethical climate and intention to leave among critical care clinicians: an observational study in 68 intensive care units across Europe and the United StatesBo Van den Bulcke, Victoria Metaxa, Anna K Reyners, et al.
Lancet (London, England)|May 8, 2007
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trialErnst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clovis Arns da Cunha, et al.
Pageof 10